NEW YORK (GenomeWeb News) - Genomic Health yesterday said third-quarter revenues bolted 124 percent, R&D spending surged 75 percent, and net loss fell by 11 percent.
 
Total receipts for the three months ended Sept. 30 increased to $15.9 million from $7.1 million year over year.
 
Product revenues from Oncotype Dx jumped 129 percent to $15.8 million from $6.9 million, while contract revenue slid 40 percent to $120,000.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.